Literature DB >> 27875664

Systemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic Dust.

Adam Wells1, Debra J Romberger1,2, Geoffrey M Thiele2,3, Todd A Wyatt1,2,4, Elizabeth Staab1, Art J Heires1,2, Lynell W Klassen2,3, Michael J Duryee2,3, Ted R Mikuls2,3, Anand Dusad3, William W West5, Dong Wang6, Jill A Poole1.   

Abstract

Airway and skeletal diseases are prominent among agriculture workers. Repetitive inhalant exposures to agriculture organic dust extract (ODE) induces bone deterioration in mice; yet the mechanisms responsible for connecting the lung-bone inflammatory axis remain unclear. We hypothesized that the interleukin (IL)-6 effector response regulates bone deterioration following inhalant ODE exposures. Using an established intranasal inhalation exposure model, wild-type (WT) and IL-6 knockout (KO) mice were treated daily with ODE or saline for 3 weeks. ODE-induced airway neutrophil influx, cytokine/chemokine release, and lung pathology were not reduced in IL-6 KO animals compared to WT mice. Utilizing micro-computed tomography, analysis of tibia showed that loss of bone mineral density, volume, and deterioration of bone micro-architecture, and mechanical strength induced by inhalant ODE exposures in WT mice were absent in IL-6 KO animals. Compared to saline treatments, bone-resorbing osteoclasts and bone marrow osteoclast precursor populations were also increased in ODE-treated WT but not IL-6 KO mice. These results show that the systemic IL-6 effector pathway mediates bone deterioration induced by repetitive inhalant ODE exposures through an effect on osteoclasts, but a positive role for IL-6 in the airway was not demonstrated. IL-6 might be an important link in explaining the lung-bone inflammatory axis.

Entities:  

Keywords:  IL-6; airway; bone; inflammation; injury; lung; mouse; organic dust; osteoclast; precursor

Mesh:

Substances:

Year:  2016        PMID: 27875664      PMCID: PMC5240004          DOI: 10.1089/jir.2016.0048

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  58 in total

Review 1.  Interleukin-6: An osteotropic factor influencing bone formation?

Authors:  Nathalie Franchimont; Sylvie Wertz; Michel Malaise
Journal:  Bone       Date:  2005-08-19       Impact factor: 4.398

2.  IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).

Authors:  Morten A Karsdal; Georg Schett; Paul Emery; Olivier Harari; Inger Byrjalsen; Andy Kenwright; Anne C Bay-Jensen; Adam Platt
Journal:  Semin Arthritis Rheum       Date:  2012-03-06       Impact factor: 5.532

3.  CD11c(+)/CD11b(+) cells are critical for organic dust-elicited murine lung inflammation.

Authors:  Jill A Poole; Angela M Gleason; Christopher Bauer; William W West; Neil Alexis; Nico van Rooijen; Stephen J Reynolds; Debra J Romberger; Tammy L Kielian
Journal:  Am J Respir Cell Mol Biol       Date:  2012-07-19       Impact factor: 6.914

4.  Effects of recombinant human interleukin-6 administration on bone in rhesus monkeys.

Authors:  N C Binkley; W H Sun; M M Checovich; E B Roecker; D B Kimmel; W B Ershler
Journal:  Lymphokine Cytokine Res       Date:  1994-08

5.  The effect of fluticasone on the airway inflammatory response to organic dust.

Authors:  A Ek; L Palmberg; K Larsson
Journal:  Eur Respir J       Date:  2004-10       Impact factor: 16.671

6.  Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.

Authors:  Laurence Duplomb; Marc Baud'huin; Céline Charrier; Martine Berreur; Valérie Trichet; Frédéric Blanchard; Dominique Heymann
Journal:  Endocrinology       Date:  2008-04-10       Impact factor: 4.736

7.  Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Nicholas Locantore; Julie Yates; Ruth Tal-Singer; Bruce E Miller; Per Bakke; Peter Calverley; Harvey Coxson; Courtney Crim; Lisa D Edwards; David A Lomas; Annelyse Duvoix; William MacNee; Stephen Rennard; Edwin Silverman; Jørgen Vestbo; Emiel Wouters; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2012-03-15       Impact factor: 21.405

8.  MyD88 in lung resident cells governs airway inflammatory and pulmonary function responses to organic dust treatment.

Authors:  Jill A Poole; Todd A Wyatt; Debra J Romberger; Elizabeth Staab; Samantha Simet; Stephen J Reynolds; Joseph H Sisson; Tammy Kielian
Journal:  Respir Res       Date:  2015-09-16

9.  Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease.

Authors:  Renata Ferrari; Suzana E Tanni; Laura M O Caram; Corina Corrêa; Camila R Corrêa; Irma Godoy
Journal:  Respir Res       Date:  2013-02-20

Review 10.  Interleukin 6 and rheumatoid arthritis.

Authors:  Yuji Yoshida; Toshio Tanaka
Journal:  Biomed Res Int       Date:  2014-01-12       Impact factor: 3.411

View more
  5 in total

Review 1.  Molecular and cellular mechanisms linking air pollution and bone damage.

Authors:  Diddier Prada; Gerard López; Helena Solleiro-Villavicencio; Claudia Garcia-Cuellar; Andrea A Baccarelli
Journal:  Environ Res       Date:  2020-04-06       Impact factor: 6.498

2.  Sex differences impact the lung-bone inflammatory response to repetitive inhalant lipopolysaccharide exposures in mice.

Authors:  Amy J Nelson; Shyamal K Roy; Kristi Warren; Katherine Janike; Geoffrey M Thiele; Ted R Mikuls; Debra J Romberger; Dong Wang; Benjamin Swanson; Jill A Poole
Journal:  J Immunotoxicol       Date:  2018-12       Impact factor: 3.000

Review 3.  The Effect of Inhalant Organic Dust on Bone Health.

Authors:  Joseph M Carrington; Jill A Poole
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

4.  A role for B cells in organic dust induced lung inflammation.

Authors:  Jill A Poole; Ted R Mikuls; Michael J Duryee; Kristi J Warren; Todd A Wyatt; Amy J Nelson; Debra J Romberger; William W West; Geoffrey M Thiele
Journal:  Respir Res       Date:  2017-12-22

5.  Ethyl pyruvate reduces organic dust-induced airway inflammation by targeting HMGB1-RAGE signaling.

Authors:  Sanjana Mahadev Bhat; Nyzil Massey; Locke A Karriker; Baljit Singh; Chandrashekhar Charavaryamath
Journal:  Respir Res       Date:  2019-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.